Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
FEBS Letters|December 31, 1997
Saposins (sap) A and C activate the degradation of galactosylceramide in living cellsK Harzer, B C Paton, H Christomanou, et al.Casopis Lekaru Ceskych|March 23, 1990
[Fabry's disease with isolated disease of the cardiac muscle, manifesting as hypertrophic cardiomyopathy]M Elleder, V Dorazilová, V Bradová, et al.American Journal of Hematology|September 2, 1998
Coincidence of Gaucher's disease due to a private mutation and Ph' positive chronic myeloid leukemiaP E Petrides, P leCoutre, J Müller-Höcker, et al.European Journal of Pediatrics|October 1, 1989
Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidosesK Harzer, B C Paton, A Poulos, et al.Journal of Comparative Pathology|August 11, 2012
GM2 gangliosidosis in an adult pet rabbitT Rickmeyer, S Schöniger, A Petermann, et al.Cell|December 11, 1997
Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cellsH Grassmé, E Gulbins, B Brenner, et al.Biochemical and Molecular Medicine|April 1, 1995
Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber diseaseT Levade, M C Tempesta, H W Moser, et al.Deutsche Medizinische Wochenschrift (1946)|January 17, 1975
[Prenatal diagnosis of Sandhoff's disease (GM2-gangliosidosis, type 2)]K Harzer, S Stengel-Rutkowski, E O Gley, et al.FEBS Letters|May 23, 1998
Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogueM Chatelut, M Leruth, K Harzer, et al.The Journal of Pathology|August 10, 1999
Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)K P Zimmer, P le Coutre, H M Aerts, et al.Pageof 11